Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD

Abstract

These findings demonstrate a role for bile acids and the bile acid dependent microbiome in the development and progression of NAFLD and set the stage to leverage these findings for NASH biomarker development and for therapeutics.